Jazz Pharmaceuticals plc — Director's Dealing 2026

Mar 2, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2026-02-27

Reporting Person: RIEDEL NORBERT G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-27	Ordinary Shares	M	3415	$138.08	Acquired	10439	Direct
2026-02-27	Ordinary Shares	S	3415	$192.0	Disposed	7024	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-27	Non-Qualified Stock Option (right to buy)	$138.08	M	3415	Disposed	2026-08-10	Ordinary Shares (3415)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	10630	Indirect

Footnotes

F1: This non-qualified stock option was granted on August 11, 2016 and vested over a period of one year from September 1, 2016. The options were fully vested as of August 1, 2017.